Experts in the US have uncovered a possible therapeutic treatment for SARS-CoV-2, the virus that results in Covid-19, and other coronaviruses.

Pathogenic coronaviruses are a significant threat to world public health, as revealed by the SARS-CoV, MERS-CoV, and the freshly emerged SARS-CoV-2.

The research, posted in the journal Science Translational Drugs, has uncovered that smaller molecule protease inhibitors demonstrate potency towards human coronaviruses.

These coronavirus 3C-like proteases, recognised as 3CLpro, are powerful therapeutic targets since they enjoy essential roles in coronavirus replication, the scientists reported.

“Vaccine developments and treatments are the most significant targets in Covid-19 analysis, and treatment is seriously key,” reported Kyeong-Ok Chang, a professor at Kansas Point out College in the US.

“This paper describes protease inhibitors targeting coronavirus 3CLpro, which is a perfectly-recognised therapeutic goal,” Chang reported.

The research demonstrates that this series of optimised coronavirus 3CLpro inhibitors blocked replication of the human coronaviruses MERS-CoV and SARS-CoV-2 in cultured cells and in a mouse product for MERS, the scientists reported.

These results advise that this series of compounds really should be investigated additional as a possible therapeutic for human coronavirus an infection, they reported.